Supreme Cannabis' 7ACRES Facility Approved for Additional 60,000 Square Feet of Production Capacity
Thursday, March 21, 2019, 8:30 AM ET
-- Licensed space at 7ACRES increases to 180,000 sqft.
-- Target annual production capacity is estimated to increase by 50% to
approximately 26,250kg.
-- Supreme Cannabis expects to submit additional rooms for Health Canada
approval in the near term.
TORONTO, March 21, 2019 /CNW/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its wholly-owned subsidiary, 7ACRES, has obtained Health Canada approval for six additional flowering rooms totaling 60,000 sqft of additional production space at its facility in Kincardine, Ontario.
Total flowering room space at 7ACRES increases from 120,000 sqft to 180,000 sqft and 7ACRES' annual production capacity estimate increases from approximately 17,500kg to 26,250kg. As noted in previous communications, Supreme Cannabis expects that with further production efficiencies following the licensing of all 25 flowering rooms, 7ACRES' potential capacity is anticipated to reach approximately 50,000kg per year by mid-2019.